New initiative aims to accelerate diagnosis and ease NHS pressures

Company seeks approval for new schedules to improve patient convenience

Application seeks reduced infusion frequency to support patient flexibility

Approval marks milestone for AI use in frontline care

New therapy offers hope for patients with limited option

Study paves the way for personalised therapies for osteoarthritis sufferer

CHMP recommendation brings new hope for patients

VYVGART could be the first CIDP drug with a novel mechanism in 30 years

Cambridge firm in-licenses two oncology programmes